RT Journal Article
SR Electronic
T1 Varicella outbreak at a nursery school under routine immunization
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.07.21256754
DO 10.1101/2021.05.07.21256754
A1 Sakaue, Tomoko
A1 Sugawara, Tamie
A1 Sugisita, Yoshiyuki
A1 Kurita, Junko
A1 Nohara, Michiko
A1 Ohkusa, Yasushi
YR 2021
UL http://medrxiv.org/content/early/2021/05/12/2021.05.07.21256754.abstract
AB Background and objective In Japan, routine administration of two-dose immunization for varicella to one-year-old children was introduced in October, 2014. The objective of this study was measurement of the effectiveness of routine two-dose immunization for varicella to onset and assessment of severity in a nursery school setting.Method The study period extended from the beginning of April, 2017 through March, 2018. The study area was Nursery school B in a city A. Subjects were 120 children in all. We analyzed vaccine efficacy (VE) as an observational study and assessed severity using Fisher’s exact test. We also assessed VE for severity using linear regression. Severity was defined as the length of school absence attributable to varicella infection.Results For one dose or more, VE was 48.1% for all ages and 49.2% among children three years old and older. No significant VE was found. Vaccination using one dose or more can reduce severity significantly.Discussion and conclusion Low VE was found in a nursery school setting, although results were not significant. VE for severity was confirmed, but a second dose might not reduce severity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by a grant from the graduate school of Tokyo Kasei University and Tokyo Women's Medical University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethical committee of Tokyo Kasei University on February 21, 2020 (No.2019-33).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe do not have any data available in public in the present study.